Advertisement

Topics

Phenomenex Inc. Company Profile

23:47 EDT 25th September 2017 | BioPortfolio


News Articles [13 Associated News Articles listed on BioPortfolio]

Phenomenex Publishes Second Edition of Comprehensive Clinical Application Notebook

This 136-page digital notebook is the second edition of the guide and presents 36 updated or entirely new applications developed by PhenoLogix™, Phenomenex’s in-house analytical developmen...

New Immobilized Lux® Chiral LC/SFC Selector from Phenomenex Delivers Broad Enantioselectivity

Phenomenex expands its Lux chiral LC/SFC column family with new immobilized Lux 5µm i-Amylose-1 and Lux 3µm i-Amylose-1 media

Phenomenex Announces Direct Sales and Support in Switzerland

Phenomenex, Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announced today that it will begin to directly serve custom...

New Immobilized Lux Chiral LC/SFC Selector From Phenomenex Delivers Broad Enantioselectivity

  Life Sciences Jobs   ...

Kinetex(R) Polar C18 Core Shell Columns Deliver High Retention and Aqueous Stability

TORRANCE, CA--(Marketwired - May 12, 2017) - Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces the Kinetex 2.6 µm Polar...

Phenomenex Offers Comprehensive Column Selection Guide For Reversed-Phase HPLC/UHPLC

  Life Sciences Jobs   ...

Phenomenex Release: New 3 ??m Particle Size Adds HPLC Scalability To Luna Omega Mixed-Mode Selectivities

  Life Sciences Jobs   ...

Phenomenex Release: Kinetex Polar C18 Core Shell Columns Deliver High Retention And Aqueous Stability

  Life Sciences Jobs   ...

Drugs and Medications [0 Results]

None

PubMed Articles [10 Associated PubMed Articles listed on BioPortfolio]

LC-MS/MS method for the simultaneous determination of Lys-MCC-DM1, MCC-DM1 and DM1 as potential intracellular catabolites of the antibody-drug conjugate trastuzumab emtansine (T-DM1).

Lysine-MCC-DM1, MCC-DM1 and DM1 are potential catabolites of trastuzumab emtansine (T-DM1). A convenient liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated to...

Development of a sensitive LC-MS/MS method for quantification of coniferyl ferulate and its metabolite coniferyl alcohol in rat plasma: Application to a pharmacokinetic study.

A rapid and simple LC-MS/MS method was developed and validated for the simultaneous determination of coniferyl ferulate (CF) and its metabolite coniferyl alcohol (CA) using bavachromene as an internal...

Development and validation of an LC-ESI-MS/MS approach to determinate a highly hydrophobic drug, Norcantharidin Palmitate, and apply to a preliminary pharmacokinetic study in rats.

In order to investigate the pharmacokinetics of norcantharidin palmitate (NCTD-PAL) in rats, we developed and validated an LC-ESI-MS/MS method. The NCTD-PAL and internal standard (Triamcinoloneacetoni...

Simultaneous determination of cucurbitacin B, E, I and E-glucoside in plant material and body fluids by HPLC-MS.

A selective and sensitive analytical method for the simultaneous determination of cucurbitacin B, E, I and E-glucoside in plant material and body fluids by HPLC-MS was developed. After liquid-liquid e...

Assessment of Lipophilicity Indices Derived from Retention Behavior of Antioxidant Compounds in RP-HPLC.

Reverse phase high pressure liquid chromatography was employed in order to evaluate the lipophilicity of antioxidant compounds from different classes, such as phenolic acids, flavanones, flavanols, fl...

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Phenomenex, Inc.

Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers i...

Phenomenex Inc.

More Information about "Phenomenex Inc." on BioPortfolio

We have published hundreds of Phenomenex Inc. news stories on BioPortfolio along with dozens of Phenomenex Inc. Clinical Trials and PubMed Articles about Phenomenex Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phenomenex Inc. Companies in our database. You can also find out about relevant Phenomenex Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record